BD BIOSCIENCES BRAND NAME - Conjugated antibodies

Closed Solicitation Posted

Solicitation number
RFQ-NIAID-25-2258428
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20814, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking to procure 64 specific BD Biosciences brand conjugated antibodies and laboratory reagents through a Request for Quotes (RFQ-NIAID-25-2258428). This is a commercial item procurement using Simplified Acquisition Procedures under Federal Acquisition Regulation Part 13, with the solicitation serving as a combined synopsis and formal request for quotations. The procurement will be conducted as a full and open competition without a small business set-aside, targeting vendors in the Biological Product Manufacturing sector (NAICS 325414). The government will evaluate quotes using the lowest price technically acceptable criteria, with potential contractors required to be registered in the System for Award Management (SAM) and comply with various Federal Acquisition Regulation provisions. Quotes must be submitted electronically to Diana Rohlman by March 28, 2025, at 4:00 PM EST, with the solicitation number included in the email subject line.

The contract will result in a firm fixed-price purchase order for delivery to the NIH/NIAID Vaccine Research Center located at 40 Convent Drive in Bethesda, Maryland. The Bill of Materials includes a comprehensive list of 64 specific antibody and laboratory reagent items, primarily from BD Biosciences, covering rat/hamster antibodies, human and mouse cell markers, and research-specific reagents. The procurement allows for companies with up to 1,250 employees to compete, with delivery designated as FOB Destination. Potential contractors must adhere to specific federal requirements, including prohibitions on contracting with entities using certain telecommunications equipment and compliance with representations and certifications outlined in the solicitation. The government intends to award the contract to a responsible contractor meeting all specified technical and administrative requirements, with the delivery to be made to the Vaccine Research Center's specific building and room location.

Notice text

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2258428 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) FAC 2025-03 January 17, 2025

The North American Industry Classification System (NAICS) code for this procurement is 325414 – 1250 employees. The requirement is being competed full and open competition, brand name restriction and without a small business set-aside.

The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for 
BD BRAND ANTIBODIES…SEE BOM LISTING ATTACHED  

Delivery Location:
NIH/NIAID
VACCINE RESEARCH CENTER
40 Convent Drive 
Bldg 40  RM # 3608B
Bethesda, MD 20814
  
FOB: Destination

* By submitting a quotation, you are accepting that all government terms and conditions set forth herein shall prevail over the award.

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based the lowest price technically acceptable. By submitting a quotation, you are accepting that all government terms and conditions set forth herein shall prevail over the award. 

The following FAR provisions apply to this acquisition: 

FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)

FAR 52.204-7 System for Award Management (NOV 24)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)

FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation
(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2023)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JAN 2025)
*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)

52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than MARCH 28, 2025 @ 4:00 PM EST

Offers may be e-mailed to Diana Rohlman (E-Mail/ diana.rohlman@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-25-2258428). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) 

All responsible sources may submit an offer that will be considered by this Agency.  
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Diana Rohlman at diana.rohlman@nih.gov.
 

Files

File Type Posted
NEW Vendor rep 52.204-26 OCT 2020.pdf PDF
4-FAR 52.212-5 Jan 2025 OVER $25K.pdf PDF
BOM - BD.xlsx XLSX spreadsheet

Similar open opportunities

Opportunity Agency Set-aside Responses due
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Pre-Clinical Models of Infectious Diseases United States · NAICS 541714 National Institute of Allergy and Infectious Diseases No set-aside
6550-- Roche Ventana Reagents IDIQ 5 Successive 1 Year Delivery Orders Slvhcs New Orleans, Louisiana 70119, United States · NAICS 325413 Veterans Integrated Service Network 16 No set-aside
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases NAICS 541715 National Institute of Allergy and Infectious Diseases No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors